Modified Simiao Yongan Decoction

Preclinical

CChengdu University of Traditional Chinese Medicine

Modified Simiao Yongan Decoction is one of 4 therapeutic programs targeting Diabetic Foot Ulcer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Diabetic Foot UlcerNot yet recruiting

Diabetic Foot UlcerPreclinical

Not yet recruiting

Competition

Competitive Landscape

4 competitors in Diabetic Foot Ulcer

#DrugCompanyPhaseTrials

L-Carnitine

IIperboreal Pharma Srl

Phase 2

1 2

BB-101

BBlue Blood Biotech Corp.

Phase 2

1 3

Propolis

IIndonesia University

Preclinical

1 4

Modified Simiao Yongan Decoction

CChengdu University of Traditional Chinese Medicine

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

PreclinicalNot yet recruiting

Diabetic Foot Ulcer

NCT07808502

Clinical

Trials by Indication[1]

Diabetic Foot Ulcer1 trial

Clinical Efficacy and Mechanism of Modified Simiao Yongan Decoction Combined With Endovascular Therapy for Diabetic Foot Ulcers (Damp-Heat Toxins Accumulation Syndrome) Based on the Vascular-Immune Microenvironment

Not yet recruiting·CChengdu University of Traditional Chinese Medicine·Preclinical·NCT07808502·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Modified Simiao Yongan Decoction. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Modified Simiao Yongan Decoction. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Chengdu University of Traditional Chinese Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: CChengdu University of Traditional Chinese Medicine

Modified Simiao Yongan Decoction

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Diabetic Foot Ulcer1 trial

References

Drug Info

Quick Facts

Related News